A GSK spokesperson confirmed that David Wentworth, who served as director of the CDC's coronavirus & other respiratory viruses division, has been appointed to a snr role in its vaccines R&D unit. His appointment was finalized in late 2024, before President Trump signaled impending federal job cuts.